TempraMed Launches National Brick and Mortar Pharmacy Roll Out, Shipping Products to Maccabi Pharmacies Across Israel 
TempraMed Launches National Brick and Mortar Pharmacy Roll Out, Shipping Products to Maccabi Pharmacies Across Israel 
Parvis Announces Second Tranche of Convertible Debenture Financing 
Parvis Announces Second Tranche of Convertible Debenture Financing 
Goldmoney Inc. Reports Results for the Quarter Ended December 31, 2025 Smiles R Us Dentistry Offers Invisalign(R) Assessment at All of Its Clinics
The Baltimore-area dental practice franchise is proud to conduct patient evaluations regarding the suitability of…
Father Francis Aning Amoah is the Subject of a New interview
The lifelong priest and Ph.D. holder sat down to discuss his life, his career, and…
Interim Report January – September 2021
GÖTEBORG, SE / ACCESSWIRE / October 22, 2021 / Smart Eye (STO:SEYE) (OTC PINK:SMTEF) (FRA:SE9)…
MYCOM OSI Named in the Global Telecoms Awards 2021 Shortlist
London, UK – Oct 22nd, 2021 – MYCOM OSI, a leading independent provider of Assurance,…
Roche’s VENTANA PD-L1 (SP263) Assay receives FDA approval as a companion diagnostic to identify certain non-small cell lung cancer patients eligible for Tecentriq® (atezolizumab)
Lung cancer remains the leading cause of cancer-related deaths worldwide, with more than 2.2 million…
Dupixent® (dupilumab) is the first biologic to significantly reduce itch and skin lesions in Phase 3 trial for prurigo nodularis, demonstrating the role of type 2 inflammation in this disease
Dupixent® (dupilumab) is the first biologic to significantly reduce itch and skin lesions in Phase…
Sio Gene Therapies Announces Reorganization of R&D Group
Two new executive positions created in connection with departure of R&D Head NEW YORK and…
PDS Biotechnology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
FLORHAM PARK, N.J., Oct. 21, 2021 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Nasdaq: PDSB), a…
Genocea to Host Third Quarter 2021 Corporate Update Conference Call & Webcast
CAMBRIDGE, Mass., Oct. 21, 2021 (GLOBE NEWSWIRE) — Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical…
Lumos Pharma to Report Third Quarter 2021 Financial Results and Host Conference Call on November 3, 2021
AUSTIN, Texas, Oct. 21, 2021 (GLOBE NEWSWIRE) — Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical-stage biopharmaceutical…
Vir Biotechnology to Provide Corporate Update and Report Third Quarter 2021 Financial Results on November 4, 2021
SAN FRANCISCO, Oct. 21, 2021 (GLOBE NEWSWIRE) — Vir Biotechnology, Inc. (Nasdaq: VIR) today announced…
Plus Therapeutics Reports Third Quarter 2021 Financial Results and Business Highlights
Management to host conference call today at 5:00 p.m. ET AUSTIN, Texas, Oct. 21, 2021…
Generation Bio to Present at Jefferies Virtual Gene Therapy/Editing Summit
CAMBRIDGE, Mass., Oct. 21, 2021 (GLOBE NEWSWIRE) — Generation Bio Co. (Nasdaq: GBIO), a biotechnology…
Codexis to Report Third Quarter 2021 Financial Results on November 4
REDWOOD CITY, Calif., Oct. 21, 2021 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq:CDXS), a leading enzyme…
T2 Biosystems Announces Distribution Agreements in Key Asia-Pacific Markets
Expands International Commercialization with Initial Shipment of T2Dx Instruments to Asia LEXINGTON, Mass., Oct. 21,…
Opiant Pharmaceuticals to Report Third Quarter 2021 Financial Results and Host Conference Call and Webcast on November 11, 2021
SANTA MONICA, Calif., Oct. 21, 2021 (GLOBE NEWSWIRE) — Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT), a…
Athira Pharma Announces Leadership Changes; Mark Litton, Ph.D., M.B.A. Named President and Chief Executive Officer; Rachel Lenington, M.B.A. Named Chief Operating Officer
Special Committee of the Board of Directors has concluded its investigation of Dr. Leen Kawas’s…
PROCEPT BioRobotics Corp. to Report Third Quarter 2021 Financial Results on November 4, 2021
REDWOOD CITY, Calif., Oct. 21, 2021 (GLOBE NEWSWIRE) — PROCEPT® BioRobotics Corporation (Nasdaq: PRCT), a…
Collegium to Host Conference Call to Discuss Third Quarter 2021 Financial Results and Provide Corporate Update
STOUGHTON, Mass., Oct. 21, 2021 (GLOBE NEWSWIRE) — Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty…
Agios to Webcast Conference Call of Third Quarter 2021 Financial Results on Nov. 3, 2021
CAMBRIDGE, Mass., Oct. 21, 2021 (GLOBE NEWSWIRE) — Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a leader…